Speakers

Sort by
Newest
Trending
1-29 of 29
Filter
Michael Flemmens
VP of Technical Business Development at SōRSE Technology
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, attention, blinded experiment, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis industry, chemical substance, clinicaltrials.gov, coffee, coffee bean, coffeehouse, coronavirus disease 2019, diesel fuel, distillation, dose (biochemistry), food, food and drug administration, hospital, ibuprofen, in vitro, innovation, laboratory, ligand (biochemistry), medication, molecule, nutraceutical, pain, pharmaceutical industry, pharmacokinetics, randomized controlled trial, red bull, solvent, starbucks, steam distillation, supercritical fluid, tetrahydrocannabinol, women's health
Austin Rhodus
Director Of Membership Services at Midwest Hemp Council
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, dose (biochemistry), food, ligand (biochemistry), medication, nutraceutical, pain, red bull, solvent, starbucks, tetrahydrocannabinol
Colby Watkins
COO at WherezHemp
absorption (pharmacology), alternative medicine, amazon (company), anti-inflammatory, anti-predator adaptation, appetite, aromatherapy, audit, bank, behavior, blog, blood alcohol content, book, botany, brand, brand loyalty, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, chemical substance, coffee, coffee bean, coffeehouse, communication, communication protocol, community, competition, customer relationship management, dose (biochemistry), drink, due diligence, email, email spam, emerging market, entourage effect, essential oil, facebook, food, food and drug administration, globalization, gluten-free diet, good manufacturing practice, google, hemp, herbal distillate, hindsight bias, insurance, juice, lemon, ligand (biochemistry), limonene, linkedin, mango, margin of error, medication, nsf international, nutraceutical, opt-in email, organic certification, pain, peer-to-peer, price, reason, red bull, regulatory compliance, risk management, sales, sales process engineering, secondary metabolite, social media, software , solvent, spectrum, starbucks, target corporation, telecommuting, terpene, terpenoid, tetrahydrocannabinol, trade, walmart, water, water activity, youtube
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Jarret Patton
CEO at Doctor Jarret PLLC
addiction, alternative medicine, anthony fauci, board certification, cancer, cannabidiol, cannabinoid, cannabis (drug), cigar, doctor of medicine, drug, electronic cigarette, emergency department, emotional intelligence, gateway drug effect, hospital, marihuana tax act of 1937, medical cannabis, medical school, medication, medicine, mind, national institute on drug abuse, opioid, opioid epidemic, organ transplantation, osteopathic medicine in the united states, pain, patient, pediatrics, physician, psychology, purdue pharma, reason, recreational drug use, red state (2011 film), residency (medicine), social stigma, substance abuse, tetrahydrocannabinol, tobacco, united states congress, walter o'brien
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Randy Fink
Physician, Medical Director at Miami Center of Excellence, LLC
alternative medicine, anesthesia, antihypertensive drug, anxiety, arm, aromatherapy, bank, bioidentical hormone replacement therapy, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, cannabis sativa, clinical trial, crohn's disease, crop insurance, curriculum, depression (mood), diarrhea, dose (biochemistry), endocannabinoid system, entourage effect, erection, evidence-based medicine, finance, food and drug administration, gastrointestinal disease, general surgery, gums, hemp, human sexual activity, ileostomy, inflammatory bowel disease, libido, medical cannabis, medical prescription, medication, mind, organized crime, orgasm, pain management, payment, pharmaceutical industry, pharmacology, pharmacy, placebo-controlled study, prescription drug, psychoactive drug, retail, route of administration, tadalafil, terminal illness, tetrahydrocannabinol, therapeutic index, transgender hormone therapy (male-to-female), ulcerative colitis
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Sean Colvin
Senior Scientist at TreeHouse Biotech
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Tyrell Towle
Director of Chemistry at MedPharm Holdings
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Julie P. Fry
Cannabis Industry Consultant
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Joshua Jones
Founder at Jonesing Labs
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Anna Schwabe
Cannabis Geneticist and Research Coordinator at Mile High Labs
alternative medicine, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis (drug), crohn's disease, drink, endocannabinoid system, entourage effect, gpr55, hash oil, immune system, immunodeficiency, liquor, moonshine, neuron, pharmaceutical industry, pharmacology, prohibition, receptor (biochemistry), tetrahydrocannabinol, weight training
Jerome Julian Grove
Co-Founder at The Physician's Choice CBD
alprazolam, alternative medicine, amitriptyline, analgesic, anesthesia, antihypertensive drug, arthritis, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, cancer, cannabinoid, carisoprodol, chiropractic, complex regional pain syndrome, crohn's disease, cyclobenzaprine, depression (mood), diabetic neuropathy, diarrhea, diazepam, diclofenac, dose (biochemistry), entourage effect, fentanyl, forecoxa, gabapentin, gastrointestinal disease, general surgery, harm reduction, heroin, ibuprofen, ileostomy, inflammatory bowel disease, lorazepam, medical cannabis, medical prescription, medication, meloxicam, methadone, muscle relaxant, naproxen, opiate, opioid, opioid epidemic in the united states, opioid use disorder, over-the-counter drug, oxycodone/paracetamol, pain management, paracetamol, paresthesia, peripheral neuropathies, peripheral neuropathy, pharmacology, pregabalin, psychoactive drug, rheumatology, route of administration, substance dependence, systemic lupus erythematosus, tapenade, terminal illness, tetrahydrocannabinol, therapeutic index, tramadol, ulcerative colitis
Karyemaitre Aliffe
Charlotte's Web
addiction, alternative medicine, analgesic, anesthesia, antihypertensive drug, benzodiazepine, big data, brand, caffeine, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, circulatory system, craft brewery and microbrewery, crohn's disease, customer, data, depression (mood), diarrhea, dose (biochemistry), drug, entourage effect, food, gastrointestinal disease, general surgery, goal, herb, herbal medicine, heroin, ileostomy, inflammatory bowel disease, major depressive disorder, mechanism of action, medical cannabis, medical prescription, medication, microwave, mirror, molecule, mood (psychology), mood disorder, natural product, nutrient, pain, pharmacology, phytochemistry, placebo, psychoactive drug, recreational drug use, route of administration, scientific method, sedative, social rejection, stress (biology), substance abuse, substance dependence, taste, terminal illness, tetrahydrocannabinol, tetraodontidae, thalidomide, therapeutic index, ulcerative colitis, vitamin, water, whole foods market, wine, wood
Steve Kazemi
COO at Precision Plant Molecules
alternative medicine, appetite, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis (drug), cannabis indica, chemotherapy, dose (biochemistry), endocannabinoid system, endocrinology, epilepsy, food and drug administration, hormone, obesity, probiotic, selective serotonin reuptake inhibitor, sleep, synthetic cannabinoids, tetrahydrocannabinol, traditional chinese medicine, vitamin c, well-being
August Dunning
Chief Science Officer at Eco Research LLC
alternative medicine, appetite, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis (drug), cannabis indica, chemotherapy, dose (biochemistry), endocannabinoid system, endocrinology, epilepsy, food and drug administration, hormone, obesity, probiotic, selective serotonin reuptake inhibitor, sleep, synthetic cannabinoids, tetrahydrocannabinol, traditional chinese medicine, vitamin c, well-being
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
David Gordon
Owner at 4 Pillars Health & Wellness
alternative medicine, amphetamine, animal testing, anti-inflammatory, antioxidant, attention deficit hyperactivity disorder, bioavailability, bong, breathing, cannabidiol, cannabinoid, cannabis, cannabis (drug), chylomicron, cytochrome p450, digestion, dispensary, dose (biochemistry), drug test, enzyme, intravenous therapy, kentucky, medical cannabis, medical school, medication, medicine, nursing, ondansetron, opiate, over-the-counter drug, pharmacogenomics, pharmacokinetics, physician, prescription drug, psychopharmacology, research, science, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy, vaporizer (inhalation device)
Graciela Moreno
Director of Member Engagement at CBD Industry Association
alternative medicine, anti-inflammatory, appetite, audit, board certification, bong, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, central processing unit, chemotherapy, convertible bond, cosmetics, crowdfunding, debenture, debt, dietary supplement, discounting, dispensary, dose (biochemistry), dravet syndrome, education, emergency medical technician, endocannabinoid system, endocrinology, epilepsy, fda food safety modernization act, financial capital, food, food and drug administration, food safety, free market, good manufacturing practice, hair loss, health claim, hormone, interest, interest rate, investment, investor, iso 9000, kentucky, medical cannabis, medical school, medication, medicine, mental disorder, mental health, mergers and acquisitions, mind, nsf international, nursing, obesity, ondansetron, opiate, option (finance), organic certification, over-the-counter drug, paramedic, pathology, pediatrics, physician, prescription drug, probiotic, psychopharmacology, quality management system, regulatory compliance, research, retail, safety, schizophrenia, selective serotonin reuptake inhibitor, sleep, social stigma, specialty (medicine), stock, stock dilution, substance abuse, syndrome, synthetic cannabinoids, tetrahydrocannabinol, therapy, tony montana, traditional chinese medicine, valuation (finance), verification and validation, vitamin c, well-being
David Turetsky
Sales and Logistics at Shi Farms
alternative medicine, alzheimer's disease, anti-inflammatory, bong, brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis sativa, chinese cuisine, cosmetics, dispensary, dose (biochemistry), farm-to-table, food and drug administration, gummy candy, health claim, kentucky, medical cannabis, medical school, medicine, nursing, nutraceutical, ondansetron, opiate, over-the-counter drug, pharmacy, physician, prescription drug, price, psychopharmacology, regulation of food and dietary supplements by the u.s. food and drug administration, research, sleep, social media, social stigma, specialty (medicine), startup company, substance abuse, target market, taste, tetrahydrocannabinol, therapy
Dave Charnick
Cannabinoid Industry Specialist at Volcanic Green Holdings
alternative medicine, anti-inflammatory, bong, cannabidiol, cannabis, cannabis (drug), dispensary, dose (biochemistry), kentucky, medical school, medicine, nursing, ondansetron, opiate, over-the-counter drug, physician, prescription drug, psychopharmacology, research, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy
Chris Hampton
Co-Owner at Hampton's Choice Holdings CBD
alternative medicine, anti-inflammatory, bong, cannabidiol, cannabis, cannabis (drug), dispensary, dose (biochemistry), kentucky, medical school, medicine, nursing, ondansetron, opiate, over-the-counter drug, physician, prescription drug, psychopharmacology, research, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy
Rob Streisfeld
CEO at BeyondBrands
absorption (pharmacology), allergy, alternative medicine, appetite, bioavailability, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, chemotherapy, chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), endocannabinoid system, endocrinology, epilepsy, food allergy, food and drug administration, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hormone, hypertension, obesity, opioid, pain, probiotic, route of administration, selective serotonin reuptake inhibitor, sleep, stress (biology), synthetic cannabinoids, tetrahydrocannabinol, therapy, traditional chinese medicine, tumor necrosis factor-alpha, vitamin c, well-being
Carter Baird
R&D Laboratory Technician at United Cannabis Corporation
absorption (pharmacology), alternative medicine, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), chemist, concussion, crohn's disease, cytochrome p450, dose (biochemistry), drink, emotion, endocannabinoid system, entourage effect, enzyme, gpr55, hash oil, immune system, immunodeficiency, liposome, liquor, memory, micelle, milk, moonshine, nanotechnology, neuroimaging, neuron, pharmaceutical industry, pharmacokinetics, pharmacology, prohibition, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol, weight training
A.J. Herrington
Freelance Writer at High Times, Merry Jane, Sensi, HEMP
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, breathing, cannabinoid, cannabis, chylomicron, cytochrome p450, digestion, dose (biochemistry), drug test, enzyme, intravenous therapy, medical cannabis, medication, medicine, pharmacogenomics, pharmacokinetics, physician, science, tetrahydrocannabinol, vaporizer (inhalation device)
Steven Bennett
Founder and Chief Scientific Officer at Prescott Logic Technologies Ltd.
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, brand, breathing, business model, cannabidiol, cannabinoid, cannabis, cannabis (drug), chylomicron, classified information, clinical trial, conversation, cytochrome p450, digestion, dose (biochemistry), drug, drug test, enzyme, facebook, food and drug administration, hashish, hemp, instagram, intravenous therapy, intrinsic safety, lobbying in the united states, market (economics), marketplace, median lethal dose, medical cannabis, medical prescription, medication, medicine, nutraceutical, over-the-counter drug, pepsi, pharmacogenomics, pharmacokinetics, pharmacology, physician, prescription drug, pressure vessel, reality, receptor (biochemistry), receptor antagonist, reputation, retail, science, shelf life, shore durometer, social media, tax, tetrahydrocannabinol, theory, understanding, vaporizer (inhalation device), washing machine, word-of-mouth marketing, xfinity
Kevin Koby
Chief Scientific Officer at Abstrax Tech
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, breathing, cannabinoid, cannabis, chylomicron, cytochrome p450, digestion, dose (biochemistry), drug test, enzyme, intravenous therapy, medical cannabis, medication, medicine, pharmacogenomics, pharmacokinetics, physician, science, tetrahydrocannabinol, vaporizer (inhalation device)
Ricardo E Rivera-Acevedo
Chief Science Officer, Adjunct Professor at Ecovita Health Corporation, University Of British Columbia
alternative medicine, amphetamine, anesthesiology, animal testing, antioxidant, attention deficit hyperactivity disorder, automation, bioavailability, biodegradation, brand, breathing, business ethics, cannabidiol, cannabinoid, cannabinol, cannabis, cell membrane, chylomicron, competition, compost, cytochrome p450, dangerous goods, digestion, dose (biochemistry), drug test, electronic cigarette, engineering, environmental remediation, enzyme, good manufacturing practice, hemp, innovation, intravenous therapy, iso 9000, labeling of fertilizer, liquid-liquid extraction, litter, litter box, medical cannabis, medication, medicine, membrane, nanofiltration, nsf international, pesticide, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, physician, plastic, pressure vessel, recycling, reputation, risk, safety, science, specification (technical standard), tetrahydrocannabinol, traceability, vaporizer (inhalation device), waste, waste management, water, water purification, water treatment
1